Skip to main content
AVLN logo

AVLN · Avalyn Pharma Inc. · Short Interest

Track AVLN — free
$25.83 -1.31 (-4.83%) At close · Oct 27
Market Cap
$1.15B
Shares
44.33M
Volume · Oct 27 961.29K Avg daily vol (3M) 257.52K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

AVLN Latest Reported Short Interest

FINRA reported 2,354,271 AVLN shares sold short as of the October 15, 2026 settlement date, a decrease of 161,983 shares. Days to cover was 6.63 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

AVLN Short Interest Forecast

Equibles' model estimates 2,490,990 shares sold short for the October 30, 2026 settlement, +5.8% versus the latest reported position, with a likely range of 2,152,302 to 2,872,465 shares. This model prediction uses FINRA data through October 27, 2026; FINRA's official release is expected November 10, 2026.

Model estimate

Expected Oct 30 short interest

as of Oct 27 High confidence 72% chance it rises
2,490,990 +5.8% vs reported
Likely range 2,152,302 to 2,872,465 The latest estimate appears in the chart below. Official release expected Nov 10. Methodology
Short Squeeze Score
52/100
Short interest 5.3% of shares — P72 Days to cover 6.6 — P77 Price vs VWAP -15.0% — P28 Short-volume trend -21.9% — P5 Short interest change -6.4% — P29 Worst FTD 0.03% of shares — P70

Positioning score 51.9 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-28 04:23 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 2,354,271 2,516,254 -161,983 6.63
2026-09-30 2,516,254 2,093,252 +423,002 8.52
2026-09-15 2,093,252 1,930,246 +163,006 9.56
2026-08-31 1,930,246 2,072,596 -142,350 11.34
2026-08-14 2,072,596 2,018,998 +53,598 10.93
2026-07-31 2,018,998 2,190,330 -171,332 9.36
2026-07-15 2,190,330 2,165,545 +24,785 5.62
2026-06-30 2,165,545 1,309,105 +856,440 3.07
2026-06-15 1,309,105 896,139 +412,966 5.53
2026-05-29 896,139 562,374 +333,765 3.22
2026-05-15 562,374 0 +562,374 1.35

Full FINRA short interest reporting calendar

Showing 1–11 of 11 settlements
Key facts CIK 1540171 CUSIP 05348Y105 13F (30d) 10 filings 10 filers Visit website Investor relations